These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 17082483

  • 1. Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway.
    Nakata S, Tsutsui M, Shimokawa H, Yamashita T, Tanimoto A, Tasaki H, Ozumi K, Sabanai K, Morishita T, Suda O, Hirano H, Sasaguri Y, Nakashima Y, Yanagihara N.
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):92-8. PubMed ID: 17082483
    [Abstract] [Full Text] [Related]

  • 2. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
    Kolyada AY, Fedtsov A, Madias NE.
    Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
    [Abstract] [Full Text] [Related]

  • 3. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
    Ye Y, Martinez JD, Perez-Polo RJ, Lin Y, Uretsky BF, Birnbaum Y.
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
    [Abstract] [Full Text] [Related]

  • 4. Vascular neuronal NO synthase is selectively upregulated by platelet-derived growth factor: involvement of the MEK/ERK pathway.
    Nakata S, Tsutsui M, Shimokawa H, Tamura M, Tasaki H, Morishita T, Suda O, Ueno S, Toyohira Y, Nakashima Y, Yanagihara N.
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2502-8. PubMed ID: 16224055
    [Abstract] [Full Text] [Related]

  • 5. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
    Wagner AH, Schwabe O, Hecker M.
    Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
    [Abstract] [Full Text] [Related]

  • 6. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice.
    Laufs U, Gertz K, Huang P, Nickenig G, Böhm M, Dirnagl U, Endres M.
    Stroke; 2000 Oct; 31(10):2442-9. PubMed ID: 11022078
    [Abstract] [Full Text] [Related]

  • 7. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
    Brouet A, Sonveaux P, Dessy C, Moniotte S, Balligand JL, Feron O.
    Circ Res; 2001 Nov 09; 89(10):866-73. PubMed ID: 11701613
    [Abstract] [Full Text] [Related]

  • 8. Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release.
    Stegbauer J, Kuczka Y, Vonend O, Quack I, Sellin L, Patzak A, Steege A, Langnaese K, Rump LC.
    Am J Physiol Regul Integr Comp Physiol; 2008 Feb 09; 294(2):R421-8. PubMed ID: 18046021
    [Abstract] [Full Text] [Related]

  • 9. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
    Gong X, Ma Y, Ruan Y, Fu G, Wu S.
    Exp Gerontol; 2014 Apr 09; 52():9-17. PubMed ID: 24463049
    [Abstract] [Full Text] [Related]

  • 10. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY, Huang KC, Chou YH, Hsieh PF, Lin KH, Lin WW.
    Mol Pharmacol; 2006 Mar 09; 69(3):960-7. PubMed ID: 16317111
    [Abstract] [Full Text] [Related]

  • 11. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H, Farrell G, Wong HJ, Yu J, Chu E, Chen J, Teoh N.
    J Gastroenterol Hepatol; 2012 Aug 09; 27(8):1353-61. PubMed ID: 22432744
    [Abstract] [Full Text] [Related]

  • 12. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
    Feron O, Dessy C, Desager JP, Balligand JL.
    Circulation; 2001 Jan 02; 103(1):113-8. PubMed ID: 11136695
    [Abstract] [Full Text] [Related]

  • 13. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J, Kathirvel K, Leo MD, Kuntamallappanavar G, Uttam Singh T, Mishra SK.
    J Cardiovasc Pharmacol; 2009 Dec 02; 54(6):526-34. PubMed ID: 19755915
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase.
    Patzak A, Steege A, Lai EY, Brinkmann JO, Kupsch E, Spielmann N, Gericke A, Skalweit A, Stegbauer J, Persson PB, Seeliger E.
    Am J Physiol Regul Integr Comp Physiol; 2008 Feb 02; 294(2):R429-37. PubMed ID: 17959704
    [Abstract] [Full Text] [Related]

  • 15. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F, Könemann S, Wolff B, Barth S, Staudt A, Kroemer HK, Dahm JB, Felix SB, Landsberger M.
    J Physiol Pharmacol; 2007 Sep 02; 58(3):503-14. PubMed ID: 17928646
    [Abstract] [Full Text] [Related]

  • 16. Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS.
    Dautzenberg M, Keilhoff G, Just A.
    J Physiol; 2011 Oct 01; 589(Pt 19):4731-44. PubMed ID: 21825026
    [Abstract] [Full Text] [Related]

  • 17. Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats.
    Kishi T, Hirooka Y, Mukai Y, Shimokawa H, Takeshita A.
    J Hypertens; 2003 Feb 01; 21(2):379-86. PubMed ID: 12569269
    [Abstract] [Full Text] [Related]

  • 18. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.
    Dichtl W, Dulak J, Frick M, Alber HF, Schwarzacher SP, Ares MP, Nilsson J, Pachinger O, Weidinger F.
    Arterioscler Thromb Vasc Biol; 2003 Jan 01; 23(1):58-63. PubMed ID: 12524225
    [Abstract] [Full Text] [Related]

  • 19. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM, Rodríguez-Criado N, Hernanz R, García-Redondo AB, Rodrigues-Díez RR, Alonso MJ, Egido J, Ruiz-Ortega M, Salaices M.
    Hypertension; 2009 Jul 01; 54(1):142-9. PubMed ID: 19451411
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.